Russia's veterinary watchdog Rosselkhoznadzor has denied state registration to Belarusian National Biotechnological Corporation's L-lysine monochloride and L-lysine sulphate, according to the state feed additive database. No reason for the rejection was given.
The project, valued at $870 million, counted Russia as a key sales market.
Blocking a major Belarusian lysine producer from Russia cuts a supply source and could tighten feed-grade lysine availability in Eastern Europe, supporting lysine prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.